Published in Br J Cancer on October 11, 2012
Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS. Br J Cancer (2014) 1.44
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget (2014) 1.05
Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma. Oncogenesis (2014) 1.01
Solid tumors of childhood display specific serum microRNA profiles. Cancer Epidemiol Biomarkers Prev (2014) 0.99
Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol (2014) 0.87
The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol (2016) 0.85
MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. Exp Ther Med (2014) 0.84
Biology of childhood germ cell tumours, focussing on the significance of microRNAs. Andrology (2014) 0.83
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer (2015) 0.83
Retracted MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. Onco Targets Ther (2014) 0.82
Decreased miR-198 expression and its prognostic significance in human gastric cancer. World J Surg Oncol (2016) 0.81
Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level. PLoS One (2014) 0.80
Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol (2015) 0.80
Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer. PLoS One (2015) 0.79
Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget (2016) 0.78
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines. PLoS One (2014) 0.77
Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs. Mol Cancer (2015) 0.77
MicroRNAs as Biomarkers in Cancer. Diagnostics (Basel) (2013) 0.77
Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma. Mol Cancer (2014) 0.77
MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. J Am Soc Nephrol (2015) 0.76
piR-651 and its function in 95-D lung cancer cells. Biomed Rep (2016) 0.75
Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p? J Cancer Res Clin Oncol (2017) 0.75
microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients. Cell Oncol (Dordr) (2017) 0.75
Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design. Invest New Drugs (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
miRNAs in human cancer. J Pathol (2010) 6.02
MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol (2011) 3.57
Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest (2005) 2.60
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem (2008) 2.44
Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res (2010) 2.39
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta (2010) 1.98
EAU guidelines on testicular cancer: 2011 update. Eur Urol (2011) 1.96
Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol (2011) 1.85
The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet (2010) 1.73
High-throughput microRNAome analysis in human germ cell tumours. J Pathol (2007) 1.60
Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res (2010) 1.59
Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol (2011) 1.19
The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One (2010) 1.18
Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One (2011) 1.15
Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors? Eur Urol (2012) 1.05
Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer (2000) 1.00
The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer (2010) 0.94
The role of tumour markers in the diagnosis and treatment of testicular germ cell cancers. Br J Urol (1997) 0.93
Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl (2007) 0.93
Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells. Biochem Biophys Res Commun (2012) 0.88
Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol (2012) 0.86
Derivation of rhesus monkey parthenogenetic embryonic stem cells and its microRNA signature. PLoS One (2011) 0.85
MicroRNAs: a new paradigm on molecular urological oncology. Urology (2010) 0.84
Serum tumor markers in the evaluation of male germ cell tumors. Nat Rev Urol (2010) 0.83
Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region. Genes Chromosomes Cancer (1997) 0.81
The value of tumor markers in testicular seminomas. Results of a prospective multicenter study. Eur Urol (1997) 0.79
Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet (1995) 3.27
Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid (2006) 2.00
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol (1996) 1.76
The expression of HMGA genes is regulated by their 3'UTR. Oncogene (2001) 1.69
CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem (1996) 1.59
Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count. Leuk Lymphoma (2007) 1.58
Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol (1993) 1.56
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene (1998) 1.52
Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Genes Chromosomes Cancer (1995) 1.49
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat (2001) 1.46
Immunoblot analysis of immune response to Campylobacter pylori and its clinical associations. J Clin Pathol (1988) 1.41
MAGE-A gene expression pattern in primary breast cancer. Cancer Res (2001) 1.34
The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer (1998) 1.33
Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog (1997) 1.33
Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther (2008) 1.26
HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene (1996) 1.26
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. Br J Cancer (2005) 1.22
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
The DAPI banded karyotype of the domestic dog (Canis familiaris) generated using chromosome-specific paint probes. Chromosome Res (1999) 1.16
Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer (1999) 1.16
Cytogenic and molecular analysis of an aggressive angiomyxoma. Am J Pathol (1995) 1.15
Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem (1997) 1.11
In situ hybridization for the detection of cytomegalovirus (CMV) infection. Application of biotinylated CMV-DNA probes on paraffin-embedded specimens. Virchows Arch A Pathol Anat Histopathol (1986) 1.11
Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch (1999) 1.09
Human papillomavirus type 13 and focal epithelial hyperplasia of the oral mucosa: DNA hybridization on paraffin-embedded specimens. Virchows Arch A Pathol Anat Histopathol (1987) 1.09
An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet (1996) 1.06
HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma (1997) 1.06
Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. Br J Cancer (2010) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer (1998) 1.04
A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat (1996) 1.04
Variation of HMGB1 expression in breast cancer. Anticancer Res (2002) 1.04
Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch (2001) 1.04
A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet (1995) 0.99
Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol (2001) 0.99
Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol (1990) 0.99
Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chromosomes Cancer (1994) 0.99
Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors. Horm Res (2000) 0.98
MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Andrology (2014) 0.97
An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Genes Chromosomes Cancer (2000) 0.97
High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol Histopathol (2003) 0.97
Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res (1995) 0.96
Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch (2000) 0.96
A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by the polymerase chain reaction. Virchows Arch A Pathol Anat Histopathol (1992) 0.96
Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol (1998) 0.95
cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am J Pathol (2001) 0.95
Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression. J Neurooncol (2001) 0.95
Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer (1995) 0.94
Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med (1994) 0.94
A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer (1999) 0.94
The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol (2011) 0.94
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg (2000) 0.93
Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet (1998) 0.93
P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch (1999) 0.92
[Differential diagnosis of basaloid salivary gland tumors]. Pathologe (2004) 0.92
Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS (1998) 0.91
Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer (2000) 0.91
Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int J Cancer (1999) 0.91
Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation T(3;12) is not sufficient for direct immortalization. Cell Biol Int Rep (1992) 0.91
Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem Biophys Res Commun (1994) 0.90
Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenet (1989) 0.90
Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet Cytogenet (1998) 0.90
Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol (1996) 0.90
Molecular characterization of the canine HMGB1. Cytogenet Genome Res (2003) 0.90
Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Cancer (1997) 0.90
Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas. Cancer Res (1995) 0.90
Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol (2001) 0.89
Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer (1995) 0.89
Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging. Cancer Genet Cytogenet (1994) 0.89
Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem (2000) 0.88
Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J Clin Endocrinol Metab (2000) 0.88
Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod (1999) 0.88
A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21). Cancer Genet Cytogenet (1997) 0.88
Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer (1991) 0.88
Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch (1999) 0.88
The significance of pericentric inversions of chromosome 2. Hum Genet (1986) 0.88
p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity. J Cancer Res Clin Oncol (1997) 0.88
Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod (1996) 0.88
Human papillomavirus (HPV) infection of cervical lesions detected by immunohistochemistry and in situ hybridization. Cancer Detect Prev (1986) 0.88
[Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors]. Pathologe (2005) 0.87
Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours. Virchows Arch A Pathol Anat Histopathol (1982) 0.87
An extended nomenclature of the canine karyotype. Cytogenet Cell Genet (1996) 0.87
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia (2003) 0.87
HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res (1998) 0.87
Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat. Oncogene (2003) 0.87
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Eur Urol (2001) 0.87
Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol (1999) 0.86
Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas. Biochem Biophys Res Commun (1995) 0.86
Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands. Histopathology (2008) 0.86
A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics (1995) 0.86
Anaplasma phagocytophilum in dogs in Germany. Zoonoses Public Health (2007) 0.86
The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol (2000) 0.85